This site is intended for healthcare professionals only
LoginRegister
Boehringer Ingelheim gets European Commission approval for Generalized Pustular Psoriasis flares treatment SpesolimabBoehringer Ingelheim gets European Commission approval for Generalized Pustular Psoriasis flares...
Bharat Serums and Vaccines bags exclusive right to market severe burns treatment NexoBrid in IndiaBharat Serums and Vaccines bags exclusive right to market severe burns treatment NexoBrid in India
Hereditary angioedema medicine: Takeda Biopharma launches CINRYZE in IndiaHereditary angioedema medicine: Takeda Biopharma launches CINRYZE in India
Takeda to acquire Oral Allosteric TYK2 Inhibitor NDI-034858 from Nimbus TherapeuticsTakeda to acquire Oral Allosteric TYK2 Inhibitor NDI-034858 from Nimbus Therapeutics
Dr Reddys Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, EuropeSubmit in vitro data and comparative data: CDSCO Tells Dr Reddy's on Icosapent Ethyl Capsule
USFDA grants accelerated approval for Mirati Therapeutics lung cancer drug KRAZATIUSFDA grants accelerated approval for Mirati Therapeutics lung cancer drug KRAZATI
Health InfrastructureAspen Pharmacare gets USD 30 million grant to make vaccines
Pfizer eyes USD 10 billion- USD 15 billion in potential revenue from mRNA vaccines by 2030Pfizer eyes USD 10 billion- USD 15 billion in potential revenue from mRNA vaccines by 2030
Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell CarcinomaMerck commences tender offer to purchase Imago BioSciences
Glenmark gets CDSCO Panel nod to Study FDC Of Bilastine, Dextromethorphan ,Phenylephrine SyrupGlenmark gets CDSCO Panel nod to Study FDC Of Bilastine, Dextromethorphan ,Phenylephrine Syrup
Entod Pharma to launch GLO division for glaucomaEntod Pharma to launch GLO division for glaucoma
Roche Pharma CEO Bill Anderson to step downRoche Pharma CEO Bill Anderson to step down
X